National News
NAFDAC halts Artemether/Lumefantrine registration
The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
Metro15 hours agoSeveral feared trapped as Two-Storey Building crumbles in Lagos
-
News1 day ago( VIDEO) Archbishop Kawas urges believers to embrace humility and live purposefully to please God
-
News15 hours agoBREAKING: Nnamdi Kanu drops plan to call witnesses in terrorism trial, says no valid charge against him
-
News1 day agoNdoma-Egba decries erosion of political values, says modern leaders have abandoned modesty of Founding Fathers
-
News1 day agoOpinion: Tinubu and the burden of Governance
-
News14 hours agoSoludo promises ₦1 Million reward to boost Voter turnout
-
Metro14 hours agoLagos Club Owner, Others nabbed as NDLEA cracks down on Drug Network
-
News14 hours agoDemolition Protest: Police warn Sowore to stay away from Lagos



